Marshall Wace North America’s Kindred Healthcare KND Stock Holding History

Marshall Wace North America’s Portfolio KND Stock Details KND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-33,606	Closed	-$303K	–	1622
2018 Q2	$303K	Sell	33,606 -591,183	-95%	-$5.3M	﹤0.01%	1190
2018 Q1	$5.72M	Buy	624,789 +391,015	+167%	+$3.62M	0.03%	538
2017 Q4	$2.27M	Buy	+233,774	New	+$1.74M	0.01%	807
2017 Q2	–	Sell	-79,917	Closed	-$639K	–	1545
2017 Q1	$639K	Buy	+79,917	New	+$626K	0.01%	775
2013 Q4	–	Sell	-22,876	Closed	-$307K	–	891
2013 Q3	$307K	Buy	+22,876	New	+$329K	0.01%	512

Marshall Wace North America's KND Position: Q3 2018 in Review

Marshall Wace North America sold out of Kindred Healthcare (KND) in Q3 2018, closing a stake of 33,606 shares — an estimated $303K sold.

Marshall Wace North America first reported a position in KND in Q3 2013 and held it in 5 quarters. The position peaked at $5.72M in Q1 2018. 0 funds tracked by Wall St. Rank hold KND as of Q3 2018.

Marshall Wace North America reported no remaining Kindred Healthcare position as of Q3 2018 after selling out during the quarter.
Marshall Wace North America sold 33,606 Kindred Healthcare shares in Q3 2018, an estimated $303K.
Marshall Wace North America first reported a position in Kindred Healthcare in Q3 2013 and held it in 5 quarters.
Marshall Wace North America's Kindred Healthcare position peaked at $5.72M in Q1 2018.
0 funds tracked by Wall St. Rank held Kindred Healthcare as of Q3 2018.

Based on Marshall Wace North America's 13F filing for Q3 2018, filed 14 Nov 2018.